Aptargroup SEC Filings

A holder of Common stock of the issuer with symbol ATR filed a notice to sell 15,000 shares through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. The shares have an indicated aggregate market value of $1,818,435.00, compared with 65,619,154 shares of the same class reported as outstanding. The seller acquired these 15,000 shares on 12/12/2025 by exercising options under a registered plan and paid the purchase price in cash on the same date.

AptarGroup, Inc. completed an underwritten public offering of $600 million aggregate principal amount of its 4.750% Senior Notes due 2031. The notes mature on March 30, 2031 and carry a fixed interest rate of 4.750% per year, paid semi-annually on March 30 and September 30, starting March 30, 2026. These notes are unsecured and rank equally with the company’s other senior unsecured debt.

The company can redeem the notes before February 28, 2031 at a make-whole price, and on or after that date at 100% of principal plus accrued interest. If a defined change of control repurchase event occurs and the notes are not redeemed, holders can require AptarGroup to repurchase their notes at 101% of principal plus accrued interest. The indenture includes typical covenants limiting certain liens, sale-leaseback transactions, and major corporate reorganizations, along with standard events of default and acceleration provisions.

AptarGroup, Inc. is issuing $600,000,000 of 4.750% Senior Notes due March 30, 2031. The notes pay interest semi-annually starting March 30, 2026 and are unsecured, unsubordinated obligations ranking equally with Aptar’s other unsecured senior debt and structurally behind liabilities at its subsidiaries. The public offering price is 99.917%, providing estimated net proceeds of about $593.9 million after fees. Aptar plans to use the proceeds to repay all $125.0 million of its 3.61% senior unsecured notes due 2025, all $125.0 million of its 3.61% senior unsecured notes due 2026, and all outstanding U.S. dollar borrowings under its revolving credit facility, with any remainder for general corporate purposes. The notes are callable at a make-whole price before February 28, 2031 and at par thereafter, and investors receive a 101% repurchase right if a defined change of control and ratings downgrade occur.

AptarGroup, Inc. plans to issue new unsecured senior notes to refinance existing borrowings. The notes rank equally with Aptar’s other unsecured debt, are structurally junior to subsidiary liabilities, and include optional redemption and a 101% repurchase feature if a change of control and ratings downgrade occur. Net proceeds are expected to repay all $125.0 million 3.61% notes due 2025, all $125.0 million 3.61% notes due 2026, and outstanding U.S. dollar borrowings under the revolving credit facility, with any remainder for general corporate purposes. Aptar reports net sales of $2,814.4 million and net income attributable to Aptar of $318.4 million for the nine months ended September 30, 2025, with Net Debt of $935.6 million and Net Debt to Net Capital of 25.1% as of that date.

AptarGroup (ATR) reported an initial Form 3 for Irene Hudson, EVP and Chief Legal Officer. She directly owns 798 shares of common stock and holds stock options for 842 shares at $111.38 expiring 03/15/2033, 1,189 shares at $141 expiring 03/15/2034, and 1,030 shares at $147.84 expiring 03/17/2035. Each option vests in three equal installments beginning on the first anniversary of the grant date.

AptarGroup (ATR) reported higher Q3 2025 revenue and earnings. Net sales rose to $961.1 million from $909.3 million, led by Aptar Pharma ($445.4 million), Beauty ($327.8 million) and Closures ($188.0 million). Operating income was $136.9 million versus $138.3 million a year ago. Other income benefited from a $26.5 million gain from remeasurement of an equity method investment.

Profitability improved year over year. Net income attributable to AptarGroup was $127.9 million (diluted EPS $1.92) versus $100.0 million ($1.48). For nine months, sales reached $2.81 billion with net income of $318.4 million (EPS $4.75) versus $2.73 billion and $273.6 million (EPS $4.05).

Balance sheet and cash flow remained solid. Cash and equivalents were $257.1 million; total assets were $5.10 billion. Net cash provided by operations was $386.3 million. The company used cash for capital expenditures ($183.6 million), treasury stock purchases ($190.0 million) and dividends ($89.3 million). Revolving credit borrowings totaled $187.0 million and €130.0 million under the amended facility. Leverage and coverage remained well within covenants at 1.22x and 17.02x, respectively. Shares outstanding were 65,619,154 as of October 27, 2025.

AptarGroup, Inc. (ATR) furnished an 8-K announcing that it released certain information related to its results of operations for the quarter ended September 30, 2025. The company provided a press release as Exhibit 99.1.

The company stated the furnished information in Item 2.02 and Exhibit 99.1 is not deemed “filed” under Section 18 of the Exchange Act and is not incorporated into other filings unless specifically referenced. AptarGroup’s common stock trades on the NYSE under the symbol ATR.

AptarGroup (ATR) insider sale by Segment President Touya Gael. The Form 4 reports that on 09/11/2025 Mr. Gael sold a total of 2,500 shares of AptarGroup common stock in two sets of transactions: 2,110 shares at a weighted-average price of $136.1325 and 390 shares at a weighted-average price of $136.0467. Following those reported sales, the filing shows beneficial ownership of 31,853 shares after the first sale and 31,463 shares after the second sale. The filing was signed by an attorney-in-fact on 09/12/2025 and includes explanations that the reported prices are weighted averages across multiple trades.

AptarGroup, Inc. (ATR) filed a Form 144 notifying the proposed sale of 2,500 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $340,297.75 and an approximate sale date of 09/11/2025. The filing reports total outstanding shares of 65,880,522, which gives context to the size of the proposed sale relative to the company's share count.

The securities listed were acquired in 2021 through restricted stock vesting under a registered plan: 603 shares on 03/25/2021, 1,126 shares on 02/28/2021 and 771 shares on 03/23/2021, each noted as payment for services rendered. The filer indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.